“… [ 66 ] | Cisplatin-Induced Bladder Cystopathy | Female SD rats | 6 mg/kg, 5 consecutive days | RBSMCs, SV-HUC-1, ATCC, Manassas, VA | NGF, HO-1 | CUR via targeting NRF2 could ameliorate cisplatin-induced cystopathy. | [ 67 ] |
Pain | Male Swiss mice | 3, 10, 30 mg/kg, subcutaneously, 1 h before stimulation | - | NF-ĸB, HO-1, TNF-α, IL-10, IL-1β | CUR via reducing NF-κB activation and increasing Nrf2 expression could inhibit superoxide anion-induced inflammatory pain-like behaviors. | [ 68 ] |
Endotoxemia | Male Wistar rats | 25,50, and 100 mg/kg, orally, 2 consecutive days | - | TNF-α, IL1-β | CUR via modulating the activity of Nrf2 could prevent LPS-induced sickness behavior and fever possibly. |
…”